Search
Showing results for "1"
News & Events
Clinic Update May 2022PCH Diabetes Service Update We will continue to utilise Telehealth for most appointments and care for the next few weeks at least, but we remain ready to pivot back to face to face care as soon as possible.
News & Events
T1D: Challenge acceptedOne step at a time … that’s the message Canadian Sebastien Sasseville wants kids living with Type 1 Diabetes to know when he talks about his T1D journey.
Our new and improved patient folder is a comprehensive resource to help families navigate a new type 1 diabetes diagnosis, now and into the future.
Research
Spatio-temporal patterns of childhood pneumonia in Bhutan: a Bayesian analysisPneumonia is one of the top 10 diseases by morbidity in Bhutan. This study aimed to investigate the spatial and temporal trends and risk factors of childhood pneumonia in Bhutan.
Research
Does Child Care in the First Year of Life Pose a Risk for Concurrent and Future Ear Infections?The longitudinal analyses found no evidence of increased (or decreased) long-term risk of ear infections in subsequent waves associated with attending a child care centre
Research
Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiologyHere, we identifyied 12 suggestively significant loci associated with intake of any macronutrient in 91,114 European ancestry participants
Research
Child and adolescent psychiatry training in Australia and New ZealandThis article highlights the requirements of the training programs for Child and Adolescent Psychiatry in Australia and New Zealand
Research
More People, More Active, More Often for Heart Health - Taking Action on Physical ActivityPhysical inactivity is a leading contributor to increased cardiovascular morbidity and mortality. Almost 500 million new cases of preventable noncommunicable diseases (NCDs) will occur globally between 2020 and 2030 due to physical inactivity, costing just over US$300 billion, or around US$ 27 billion annually (WHO 2022). Active adults can achieve a reduction of up to 35% in risk of death from cardiovascular disease.
Research
Development of a pharmaceutical science systematic review process using a semi-automated machine learning tool: Intravenous drug compatibility in the neonatal intensive care settingOur objective was to establish and test a machine learning-based screening process that would be applicable to systematic reviews in pharmaceutical sciences. We used the SPIDER (Sample, Phenomenon of Interest, Design, Evaluation, Research type) model, a broad search strategy, and a machine learning tool (Research Screener) to identify relevant references related to y-site compatibility of 95 intravenous drugs used in neonatal intensive care settings.